The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Sensitization of Calcitonin Gene-Related Peptide Receptors by Receptor Activity-Modifying Protein-1 in the Trigeminal Ganglion
Open accessAbstract
The neuropeptide calcitonin gene-related peptide (CGRP) from the trigeminal ganglion has been established as a key player in the pathogenesis of migraine. In this study, we provide evidence that the responsiveness of neuronal CGRP receptors is strongly enhanced in vitro and in vivo by expression of human receptor activity-modifying protein-1 (hRAMP1), an obligatory subunit of the CGRP receptor. We first demonstrated that activation of CGRP receptors on cultured trigeminal ganglion neurons increased endogenous CGRP mRNA levels and promoter activity. The promoter activation was cAMP dependent and blocked by the antagonist BIBN4096BS [1-piperidinecarboxamide,N-[2-[[5-amino-l-[[4-(4-pyridinyl)-l-piperazinyl]carbonyl]pentyl]amino]-1-[(3,5-dibromo-4-hydroxyphenyl)methyl]-2-oxoethyl]-4-(1,4-dihydro-2-oxo-3(2 H)-quinazolinyl)], a new antimigraine drug. Gene transfer using an adenoviral hRAMP1 expression vector increased the maximal production of cAMP by 1.8 ± 0.2-fold and decreased the EC 50 to 2.3 ± 0.8 n m from 9.0 ± 5.9 n m and 15.6 ± 5.2 n m in uninfected and control-infected cultures, respectively. To establish whether RAMP1 is limiting in vivo as indicated from the culture studies, a transgenic mouse expressing hRAMP1 in the nervous system was generated. After CGRP injection into the whiskerpad, the hRAMP1 transgenic mice displayed 2.2 ± 0.2-fold greater plasma extravasation, which is a measure of neurogenic inflammation. These results demonstrate that RAMP1 is functionally rate limiting for CGRP receptor activity in the trigeminal ganglion, which raises the possibility that elevated RAMP1 might sensitize some individuals to CGRP actions in migraine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
‘Green mice’ as a source of ubiquitous green cells
Okabe, M., Ikawa, M., Kominami, K., Nakanishi, T., & Nishimune, Y. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00313-x · Cited by 2,581
RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
McLatchie, L. M., Fraser, N. J., Main, M. J., Wise, A., Brown, J., Thompson, N., Solari, R., Lee, M. G., & Foord, S. M. (1998) · Nature · doi:10.1038/30666 · Cited by 2,134
Poyner, D. R., Sexton, P. M., Marshall, I., Smith, D. M., Quirion, R., Born, W., Muff, R., Fischer, J. A., & Foord, S. M. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.233 · Cited by 804 · cited 6×
“A second, less prevalent CGRP receptor has been suggested, although its molecular identity remains unclear (Poyner et al., 2002).”
BackgroundResultInfluentialVascular Actions of Calcitonin Gene-Related Peptide and Adrenomedullin
Brain, S. D., & Grant, A. D. (2004) · Physiological Reviews · doi:10.1152/physrev.00037.2003 · Cited by 765
Christopoulos, G., Perry, K. J., Morfis, M., Tilakaratne, N., Gao, Y., Fraser, N. J., Main, M. J., Foord, S. M., & Sexton, P. M. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.1.235 · Cited by 486
Dikalova, A., Clempus, R., Lassègue, B., Cheng, G., McCoy, J., Dikalov, S., Martin, A. S., Lyle, A., Weber, D. S., Weiss, D., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.538934 · Cited by 438
Hay, D. L., Poyner, D. R., & Sexton, P. M. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.06.015 · Cited by 239
Research works printed but not linked: 51
- 10.1023/A:1006962221332 · DOI
- 10.1111/j.1471-4159.2004.02833.x · DOI
- 10.1242/jcs.02598 · DOI · Paper page
- 10.1210/en.140.6.2883 · doi:10.1210/en.140.6.2883
- 10.1124/mol.59.6.1533 · DOI
- 10.1074/jbc.C200629200 · DOI · Paper page
- 10.1002/cne.20669 · DOI
- 10.1016/j.bbrc.2004.10.205 · DOI
- 10.1042/0264-6021:3510095 · doi:10.1042/0264-6021:3510095 · Paper page
- 10.1002/dvg.20226 · DOI · Paper page
- 10.1056/NEJMp048016 · doi:10.1056/nejmp048016
- Durham, 1999, Regulation of calcitonin gene-related peptide secretion by a serotonergic antimigraine drug, J Neurosci, 19, 3423, 10.1523/JNEUROSCI.19-09-03423.1999 · DOI · Paper page
- Durham, 2003, Stimulation of the calcitonin gene-related peptide enhancer by mitogen-activated protein kinases and repression by an antimigraine drug in trigeminal ganglia neurons, J Neurosci, 23, 807, 10.1523/JNEUROSCI.23-03-00807.2003 · DOI
- 10.1016/j.brainres.2003.11.005 · DOI
- 10.1016/S0304-3940(97)00456-4 · DOI
- 10.1016/S0014-2999(01)01532-1 · DOI
- 10.1074/jbc.M005604200 · DOI · Paper page
- 10.1523/JNEUROSCI.0647-06.2006 · DOI · Paper page
- 10.1016/S0306-4522(03)00163-5 · DOI
- 10.1523/JNEUROSCI.0869-05.2005 · DOI
- 10.1006/bbrc.2000.2552 · DOI
- 10.1046/j.1468-2982.1995.1505384.x · doi:10.1046/j.1468-2982.1995.1505384.x · Paper page
- 10.1074/jbc.270.35.20599 · DOI · Paper page
- 10.1038/nrd1822 · DOI
- 10.1517/14728214.11.3.419 · DOI
- 10.1002/ana.410280213 · DOI · Paper page
- 10.1056/NEJMra010917 · DOI · Paper page
- 10.1016/S0896-6273(01)00374-9 · DOI · Paper page
- 10.1111/j.1749-6632.1998.tb11158.x · DOI
- 10.1124/mol.106.027953 · DOI
- 10.1016/S0006-8993(98)00269-8 · doi:10.1016/s0006-8993(98)00269-8
- 10.1016/j.pain.2003.09.008 · DOI · Paper page
- 10.1046/j.1468-2982.2002.00310.x · DOI · Paper page
- 10.1002/ana.20619 · DOI · Paper page
- 10.1016/S0306-4522(03)00159-3 · DOI
- 10.1016/S0006-8993(01)02888-8 · DOI
- Moreno, 1999, Functional calcitonin gene-related peptide type 1 and adrenomedullin receptors in human trigeminal ganglia, brain vessels, and cerebromicrovascular or astroglial cells in culture, J Cereb Blood Flow Metab, 19, 1270, 10.1097/00004647-199911000-00012 · DOI
- 10.1016/S0028-3908(02)00008-4 · DOI
- 10.1210/en.140.6.2924 · doi:10.1210/en.140.6.2924 · Paper page
- 10.1016/j.pain.2005.04.002 · DOI
- 10.1056/NEJMoa030505 · DOI · Paper page
- Oliver, 2002, Immunohistochemical localization of calcitonin receptor-like receptor and receptor activity-modifying proteins in the human cerebral vasculature, J Cereb Blood Flow Metab, 22, 620, 10.1097/00004647-200205000-00014 · DOI
- 10.1016/S0306-4522(01)00547-4 · DOI
- 10.1038/sj.bjp.0705807 · DOI · Paper page
- 10.1152/jn.01293.2005 · DOI · Paper page
- 10.1161/01.RES.0000200737.63865.58 · DOI
- 10.1016/j.brainresrev.2004.11.006 · DOI · Paper page
- 10.1038/12703 · DOI · Paper page
- 10.1016/S0304-3959(00)00439-5 · DOI
- 10.1159/000087190 · DOI
- 10.1210/en.2005-0918 · DOI
Cited by
Pietrobon, D., & Moskowitz, M. A. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183717 · Cited by 680
A Phase‐by‐Phase Review of Migraine Pathophysiology
Dodick, D. W. (2018) · Headache: The Journal of Head and Face Pain · doi:10.1111/head.13300 · Cited by 505
Amylin: Pharmacology, Physiology, and Clinical Potential
Hay, D. L., Chen, S., Lutz, T. A., Parkes, D. G., & Roth, J. D. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010629 · Cited by 400
CGRP physiology, pharmacology, and therapeutic targets: migraine and beyond
Russo, A. F., & Hay, D. L. (2023) · Physiological Reviews · doi:10.1152/physrev.00059.2021 · Cited by 382
Self-citationEftekhari, S., Salvatore, C. A., Calamari, A., Kane, S. A., Tajti, J., & Edvinsson, L. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.05.016 · Cited by 329
Metadata
- Authors
- Zhang, Z., Winborn, C. S., Marquez de Prado, B., & Russo, A. F.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2007-03-07
- Volume
- 27
- Issue
- 10
- Pages
- 2693-2703
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2038864055
- Cited by
- 234
- References
- 7
- FWCI
- 11.28
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sensitization of Calcitonin Gene-Related Peptide Receptors by Receptor Activity-Modifying Protein-1 in the Trigeminal Ganglion. https://app.cochat.ai/papers/10.1523/jneurosci.4542-06.2007
- The paper
- Zhang, Z., Winborn, C. S., Marquez de Prado, B., & Russo, A. F. (2007). Sensitization of Calcitonin Gene-Related Peptide Receptors by Receptor Activity-Modifying Protein-1 in the Trigeminal Ganglion. The Journal of Neuroscience. https://doi.org/10.1523/jneurosci.4542-06.2007
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.